|
gptkbp:instanceOf
|
gptkb:disease
|
|
gptkbp:affects
|
animals
humans
|
|
gptkbp:affectsOrgan
|
gptkb:skin
lungs
central nervous system
|
|
gptkbp:alsoKnownAs
|
gptkb:European_blastomycosis
torulosis
|
|
gptkbp:causedBy
|
gptkb:Cryptococcus_neoformans
gptkb:Cryptococcus_gattii
|
|
gptkbp:complication
|
death
meningoencephalitis
|
|
gptkbp:diagnosedBy
|
lumbar puncture
CSF analysis
cryptococcal antigen test
fungal culture
|
|
gptkbp:firstDescribed
|
1894
|
|
gptkbp:hasEpidemiology
|
worldwide distribution
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Cryptococcosis
|
|
gptkbp:ICD-10_code
|
B45
|
|
gptkbp:mortalityRate
|
high in untreated cases
|
|
gptkbp:notableCase
|
AIDS-related cryptococcal meningitis
|
|
gptkbp:prevalence
|
higher in immunocompromised individuals
|
|
gptkbp:prevention
|
no vaccine available
|
|
gptkbp:riskFactor
|
gptkb:HIV/AIDS
immunosuppression
|
|
gptkbp:symptom
|
confusion
fever
meningitis
headache
cough
shortness of breath
chest pain
|
|
gptkbp:transmission
|
inhalation of fungal spores
|
|
gptkbp:treatment
|
gptkb:amphotericin_B
gptkb:fluconazole
gptkb:flucytosine
|
|
gptkbp:bfsParent
|
gptkb:disease
|
|
gptkbp:bfsLayer
|
4
|